LYNN SCHNEIDER: Open Payments
NPI 1558371344 · PLATTSBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$800 in 37 payments from 12 companies in 2025. Trend: 2023 $983 · 2024 $690 · 2025 $800
Food & beverage: $800
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $240 |
| AstraZeneca Pharmaceuticals LP | 6 | $136 |
| Novo Nordisk Inc | 6 | $121 |
| PFIZER INC. | 3 | $62 |
| Lilly USA, LLC | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Lundbeck LLC | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Boston Scientific Corporation | 1 | $24 |
Products named: UBRELVY, QULIPTA, FARXIGA, Ozempic, Wegovy, MOUNJARO, NURTEC ODT, REXULTI.
Industry payments across NY — which companies pay providers there.
